World / Health & Beauty
Sciele Pharma Completes Phase III Safety Trial For Glycopyrrolate Liquid, A Treatment For Chronic, Moderate-to-Severe Drooling In Pediatric Patients
10.07.2008 09:15
medicalnewstoday.com
Sciele Pharma, Inc. (NASDAQ:SCRX) announced that it has completed its phase III safety trial utilizing a liquid formulation of glycopyrrolate to treat chronic, moderate-to-severe drooling in pediatric patients. This condition often results from cerebral palsy as well as from other neurological disorders. This trial was designed to evaluate safety parameters for glycopyrrolate over a six-month period.
World
Children Diseases
In Norway Vaccinated Infants Well Protected Against Severe Pneumococcal Infection
10.07.2008 09:15
medicalnewstoday.com
In 2006, a pneumococcal vaccine (Prevenar®) was introduced in the childhood vaccination programme in Norway. Two years later, the experiences have been published in the journal Vaccine. The results show a strong decline in serious pneumococcal infections among young children. Pneumococcus is a bacterium that can cause serious illnesses in some young children, e.g. meningitis, blood poisoning and pneumonia.
World
Immunology
Samaritan's HIV Drug Granted IND From FDA
10.07.2008 09:15
medicalnewstoday.com
Samaritan Pharmaceuticals (OTCBB:SPHC), a biopharmaceutical company committed to commercializing new innovative therapeutic drugs, announced that it has filed an IND (Investigational New Drug) application for SP-6310 in the treatment of HIV-infected patients with abnormal cortisol levels. Following discussions and protocol agreement with U.S.
World
HIV/AIDS
Women Who Use Microbicides, Still Contract HIV Could End Up With Fewer Treatment Options Because Of Resistance, Study Finds
10.07.2008 09:14
medicalnewstoday.com
Women who use microbicides in an effort to protect themselves from HIV could end up with fewer treatment options if they contract the virus because of possible drug resistance, according to a study published Monday in the Proceedings of the National Academy of Sciences, Reuters reports.
World
HIV/AIDS
Meda: FDA Approves Azelastine Eye Drops Unit Dose
10.07.2008 09:14
medicalnewstoday.com
The U.S. Food and Drug Administration (FDA) has approved Meda's (STO:MEDAA) registration application for azelastine eye drops in unit dose (Optivar Unit Dose). The substance azelastine is an antihistamine and the eye drop formulation is approved for treatment of allergic conjunctivitis in adults and pediatrics. Meda is conducting a broad development program for the azelastine substance, both as azelastine eye drops and azelastine nasal spray.
World
Eyesight Disorders
EpiVax Receives 600,000 Dollars Grant To Develop Treatment For Diabetes From National Institutes Of Health
10.07.2008 09:14
medicalnewstoday.com
EpiVax, Inc, a leader in the field of computational immunology, announced that it has received a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a division of the National Institutes of Health (NIH), to develop "Epi-13", a novel therapeutic for the prevention and treatment of Type 1 diabetes, a devastating and chronic autoimmune disease that affects three million Americans.
World
Diabetes
Mathematical Models Of Energy Homeostasis
10.07.2008 09:14
medicalnewstoday.com
To tackle diabetes and obesity, clinicians are now turning to mechanism-based mathematical models to reach quantitative diagnoses of insulin resistance, glucose intolerance and obesity, and to predict the likely outcomes of therapeutic interventions. A massive range of such models is available, which renders a judicious choice difficult.
World
Diabetes
Depression After Stroke: A Neglected Problem
10.07.2008 09:14
medicalnewstoday.com
People who have had a stroke and the people who are close to them need more support in order to manage the consequences of stroke. As well as the physical disabilities, the psychological burden is difficult to cope with. It is not only stroke patients who become depressed: their friends and relatives often become depressed too. The German Institute for Quality and Efficiency in Health Care (IQWiG) has now assessed research on treatments for depression after a stroke.
World
Depression
Aerosol Toxins From Red Tides May Cause Long-Term Health Threat
10.07.2008 09:13
medicalnewstoday.com
NOAA scientists reported in the current issue of the journal Environmental Health Perspectives that an algal toxin commonly inhaled in sea spray, attacks and damages DNA in the lungs of laboratory rats. The findings document how the body's way of disposing the toxin inadvertently converts it to a molecule that damages DNA. Human inhalation of brevetoxins produced by the red tide organism, Karenia brevis, is an increasing public health concern.
World
Cancer
A World Novelty For An Improved Tsunami Early Warning
10.07.2008 09:13
medicalnewstoday.com
After completing their simulation component in the German-Indonesian Tsunami Early Warning System (GITEWS), the team for tsunami modelling of the Alfred Wegener Institute for Polar and Marine Research in the Helmholtz Association has presented the currently leading software system for tsunami events with the potential for catastrophe. It is now being integrated into the Decision Support System (DSS) of the German Aerospace Center in Oberpfaffenhofen.
World
First Aid
From Felling to Trees to Tree Nuts
10.07.2008 08:21
beyondallergy.com
I hope you can follow this segue I am about to present, because I want to share how I came upon this information that I feel is too good, and too debatable, to let it pass us by. It started from this…We just had a number of trees cut down in our yard, from a [...]
World
Allergy
Getting Ready for College
10.07.2008 08:19
beyondallergy.com
It’s that time of year… Though it’s only early July, for those of you heading off to college, or for those of you with children heading off to college, it’s probably the foremost thing on your mind. There’s excitement, nervousness, anticipation and a whole gamut of other emotions you are probably going through. If you [...]
World
Allergy
International Organizations And IAEA Member States To Test Emergency Plans
10.07.2008 08:16
medicalnewstoday.com
In an effort to strengthen public health emergency response, the World Health Organization (WHO) will take part in a test of radiation emergency plans through a simulated accident at the Laguna Verde Nuclear power plant, Mexico, 9-10 July 2008. This exercise is coordinated by the International Atomic Energy Agency (IAEA).
World
Radiology
Verbally Aggressive Mothers Direct Their Children's Behavior
10.07.2008 08:16
medicalnewstoday.com
A new study in Human Communication Research reveals that verbally aggressive (VA) mothers tend to control their children's choice of activities as well as use physical negative touch, along with directives, when trying to alter their child's actions. Researchers led by Steven R. Wilson of Purdue University videotaped forty mothers as they completed a ten minute play period with one of their children between the ages of three and eight years.
World
Children Diseases
Studying How Food Affects The Brain
10.07.2008 08:16
medicalnewstoday.com
In addition to helping protect us from heart disease and cancer, a balanced diet and regular exercise can also protect the brain and ward off mental disorders. "Food is like a pharmaceutical compound that affects the brain," said Fernando Gomez-Pinilla, a UCLA professor of neurosurgery and physiological science who has spent years studying the effects of food, exercise and sleep on the brain.
World
Neurology
English